About the Packard Center
Founded in early 2000 at John’s Hopkins, the Robert Packard Center for ALS Research has been committed to researching a cure for this debilitating disease. The Packard Center is the only institution of its kind to dedicate its research solely to Lou Gehrig’s disease.
While the Robert Packard Center exists within the Johns Hopkins University School of Medicine, roughly two-thirds of their ALS investigators conduct research from other institutions worldwide. Today, over 100 scientists from John’s Hopkins, other universities and biotech companies work together to understand the biology of ALS and find a cure.
To learn more about the Packard Center’s research projects visit their website at www.packardcenter.org.
What is Amyotrophic Lateral Sclerosis (ALS)?
ALS (amyotrophic lateral sclerosis), otherwise known as Lou Gehrig’s Disease, is a progressive neurodegenerative disease that affects neurons in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. There is currently no cure or life-prolonging treatments for the disease.
Arbor Assays Research The Cure™ Program
At Arbor Assays, we believe we should be proactive in giving back to the community. We are offering our Research The Cure™ program for the 10th consecutive year. This program helps support important medical research with a portion of proceeds from every purchase going directly to a chosen charity.
Each year, we donate to a different charity. If you have a recommendation for future Research the Cure™ beneficiaries click here to send us your suggestion.